Substance P-induced cycloxygenase-2 expression in polymorphonuclear cells

Inflammation Research

Volumn 57, Issue SUPPL. 1, 2008, Pages

  Gallicchio, M ^a   Benetti, E ^a   Rosa, A C ^a   Fantozzi, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; RECEPTOR PROTEIN; SUBSTANCE P;

CONFERENCE PAPER; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; POLYMORPHONUCLEAR CELL; PROTEIN EXPRESSION;

CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME INDUCTION; HUMANS; NEUTROPHILS; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 43249086423     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-0608-0     Document Type: Conference Paper

References (8)

1. Patacchini R, Maggi CA. Tachykinin receptors and receptor subtypes. Arch Int Pharmacodyn Ther 1995; 329: 161-84.
2. Foreman JC, Jordan CC. Neurogenic inflammation. Trends Pharmacol Sci 1984; 5: 116-9.
3. Harrison S, Geppetti P. Substance P. Int J Biochem Cell Biol 2001; 33: 555-76.
4. Dianzani C, Collino M, Lombardi G, Garbarino G, Fantozzi R. Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br J Pharmacol 2003; 139: 1103-10.
5. Dianzani C, Lombardi G, Collino M, Ferrara C, Cassone MC, Fantozzi R. Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils. J Leukoc Biol 2001; 69: 1013-8.
6. Brunelleschi S, Tarli S, Giotti A, Fantozzi R. Priming effects of mammalian tachykinins on human neutrophils. Life Sci 1991; 48: PL 1-5.
7. Gallicchio M, Rosa AC, Benetti E, Collino M, Dianzani C, Fantozzi R. Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells. Br J Pharmacol 2006; 147: 681-9.
8. 2 production by human nasal epithelial cells. Allergy Asthma Proc 2001; 22: 17-23.